{"database":"bioimages","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"submitter":["Yuting Sun"],"journal":["The Journal of Cell Biology"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-JCBD-200912093"],"attach_to":["JCB"],"legend":["H&E staining of cross-sectin of mouse TA muscle under regeneration, day 14 post damage, vehicle treated.","MHC (Green) and DAPI (Blue) staining of anti-miR-1 transfected, follistatin treated C2C12 cells.<br />","MHC (Green) and DAPI (Blue) staining C2C12 cells.","H&E staining of cross-sectin of mouse TA muscle under regeneration, day 7 post damage, vehicle treated.","MHC (Green) and DAPI (Blue) staining of IGFII, Rapamycin and follistatin treated C2C12 cells.<br />","MHC (Green) and DAPI (Blue) staining of anti-miR-1 transfected C2C12 cells.<br />","Fig S3_miR-1 probe_vehicle<br />ISH with miR-1 probe, cross-section of mouse TA muscle under regeneration, vehicle treated.","MHC (Green) and DAPI (Blue) staining of anti-miR-1 transfected, TSA treated C2C12 cells.<br />","MHC (Green) and DAPI (Blue) staining of C2C12 cells stably expressing Flag-mTOR RR/KI (Rapamycin-resistant, kinase-inactive) mutant, treated with Rapamycin and TSA.","H&E staining of cross-sectin of mouse TA muscle under regeneration, day 14 post damage, Rapamycin and TSA treated.","MHC (Green) and DAPI (Blue) staining of a scrambled oligo transfected C2C12 cells.","MHC (Green) and DAPI (Blue) staining of C2C12 cells stably expressing Flag-mTOR RR/KI (Rapamycin-resistant, kinase-inactive) mutant, treated with Rapamycin.","H&E staining of cross-sectin of mouse TA muscle under regeneration, day 14 post damage, Rapamycin treated.","Fig S3_miR-1 probe_Rap<br />ISH with miR-1 probe, cross-section of mouse TA muscle under regeneration, rapamycin treated.<br />","Fig S3_scramble probe_vehicle<br />ISH with scrambled probe, cross-section of mouse TA muscle under regeneration, vehicle treated.<br />","MHC (Green) and DAPI (Blue) staining of C2C12 cells stably expressing Flag-mTOR RR/KI (Rapamycin-resistant, kinase-inactive) mutant, treated with Rapamycin and follistatin.","H&E staining of cross-sectin of mouse TA muscle under regeneration, day 1 post damage, vehicle treated.","Fig S3_enlarged panel_miR-1 and DAPI<br />overlay image of miR-1 ISH (blue) and DAPI (green), cross-section of mouse TA muscle under regeneration, vehicle treated.<br />","MHC (Green) and DAPI (Blue) staining of IGFII and Rapamycin treated C2C12 cells.","MHC (Green) and DAPI (Blue) staining of C2C12 cells stably expressing Flag-mTOR RR/KI (Rapamycin-resistant, kinase-inactive) mutant, treated with Rapamycin and conditioned media.","H&E staining of cross-sectin of mouse TA muscle under regeneration, day 14 post damage, Rapamycin and follistatin treated."],"repository":["bioimages"],"figure_sub":["Image 10654 (Figure 6 - B)","Image 10656 (Figure 9 - A)","Image 17718 (SupFigure  3 - None)","Figure 10 - B","SupFigure  3 - None","Image 10725 (Figure 10 - B)","Image 10722 (Figure 10 - B)","SupFigure  3","Figure 9 - B","Figure 9 - A","Image 10653 (Figure 6 - B)","Image 17715 (SupFigure  3 - None)","Image 10721 (Figure 9 - B)","Image 17716 (SupFigure  3 - None)","Image 10723 (Figure 10 - B)","Image 10726 (Figure 10 - B)","Image 10658 (Figure 9 - A)","Image 10652 (Figure 6 - B)","Image 10733 (Figure 9 - B)","Image 10718 (Figure 9 - B)","Figure 6","Image 10655 (Figure 6 - B)","Figure 10","Image 10724 (Figure 10 - B)","Figure 9","Image 10657 (Figure 9 - A)","Image 17717 (SupFigure  3 - None)","Image 10727 (Figure 10 - B)","Figure 6 - B","Image 10719 (Figure 9 - B)"],"pubmed_authors":["Yuting Sun","Jenny Drnevich","Yong Zhao","Jie Chen","Yejing Ge","Mark Band"],"additional_accession":[]},"is_claimable":false,"name":"Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis","description":null,"dates":{"release":"2010-06-21T11:19:34Z","modification":"2018-11-29T11:19:34Z","creation":"2018-11-29T11:19:34Z"},"accession":"S-JCBD-200912093","cross_references":{"doi":["10.1083/jcb.200912093"]}}